Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
接受抗病毒药物、抗疟疾药物、糖皮质激素或使用托珠单抗或环孢素进行免疫调节治疗的重症 COVID-19 住院成年患者的临床特征和结局：一项回顾性观察研究（COQUIMA 队列）
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2020.100591
Guisado-Vasco, Pablo; Valderas-Ortega, Sofia; Carralón-González, Maria Maravillas; Roda-Santacruz, Ana; González-Cortijo, Lucia; Sotres-Fernández, Gabriel; Martí-Ballesteros, Eva María; Luque-Pinilla, José Manuel; Almagro-Casado, Elena; La Coma-Lanuza, Félix J; Barrena-Puertas, Ruth; Malo-Benages, Esteban Javier; Monforte-Gómez, María José; Diez-Munar, Rocío; Merino-Lanza, Esther; Comeche-Casanova, Lorena; Remirez-de-Esparza-Otero, Margarita; Correyero-Plaza, María; Recio-Rodríguez, Manuel; Rodríguez-López, Margarita; Sánchez-Manzano, María Dolores; Andreu-Vázquez, Cristina; Thuissard-Vasallo, Israel John; María-Tomé, José María Echave-Sustaeta; Carnevali-Ruiz, Daniel
